Avantor Corporation, a supplier of ultrapure materials to the life sciences and high-tech industries, has agreed to acquire Masterflex’s bioprocessing business and related assets of Antylia Scientific, a life sciences instrument company, for $2.9 billion.
Masterflex is a US manufacturer of peristaltic pumps and single-use sterile fluid transfer technologies with estimated revenues of approximately $300 million in 2022. The acquisition strengthens Avantor’s offering in bioproduction products.
The all-cash transaction is valued at $2.9 billion, subject to final adjustments upon closing.
Given the expected tax benefits from the transaction structure, the net purchase price is approximately $2.7 billion.
The transaction is expected to be completed in the fourth quarter of 2021, and is subject to usual closing conditions, including receipt of applicable regulatory approvals.